CLASS II Drug recall · Reported 26 May 2021 · FDA Enforcement Report
Leucovorin Calcium for Injection recalled by Teva Pharmaceuticals U
Teva Pharmaceuticals USA is recalling Leucovorin Calcium for Injection, equivalent to leucovorin 350 mg/vial (20 mg/mL), distributed nationwide in the US. The recall was initiated on 26 Apr 2021 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0374-2021
- FDA event ID
- 87875
- Recalling firm
- Teva Pharmaceuticals USA, Parsippany, NJ
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 26 Apr 2021
- FDA classified
- 14 May 2021
- Reported
- 26 May 2021
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 26 Apr 2021 | Recall initiated by company | |
| 14 May 2021 | Classified by FDA | +18 days |
| 26 May 2021 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Leucovorin Calcium for Injection, equivalent to leucovorin 350 mg/vial (20 mg/mL), Rx Only, FOR IM or IV Use, Sterile, Teva Parenteral Medicines, Inc., Irvine, CA NDC 0703-5145-01; ALSO LABELED UNDER: NOVAPLUS, Manufactured By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0703-5145-91 (Novaplus, a registered trademark of Vizient, Inc.)
Where it was distributed
Product was distributed nationwide.
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility
Which lots are affected?
NDC 0703-5145-01: Lot # 31325332B, exp. date 08/2021, Lot # 31325756B, exp. date 09/2021 AND NDC 0703-5145-91: Lot # 31325685B, exp. date 09/2021
Where was it sold?
Product was distributed nationwide.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
4 other products · FDA event 87875This product is part of a recall event; the main page for the event is Haloperidol Decanoate Injection, USP 50 mg/mL Single Dose Vials recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Haloperidol Decanoate Injection, USP 50 mg/mL Single Dose Vials recalled | Teva Pharmaceuticals USA | Sterility | Nationwide | |
| CLASS II | Metoclopramide Injection USP, 10 mg/ (5 mg/mL) Single-Use Vial recalledMetoclopramide | Teva Pharmaceuticals USA | Sterility | Nationwide | |
| CLASS II | Haloperidol Decanoate Injection, USP 100 mg/mL Single Dose Vials recalled | Teva Pharmaceuticals USA | Sterility | Nationwide | |
| CLASS II | Methylprednisolone Acetate Injectable Suspension recalled | Teva Pharmaceuticals USA | Sterility | Nationwide |
More recalls from Teva Pharmaceuticals USA
All 280| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | traZODone Hydrochloride Tablets, USP, 50 mg recalledTrazodone Hydrochloride | Teva Pharmaceuticals USA | Other | Nationwide |
| Drug | CLASS II | Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate | Teva Pharmaceuticals USA | Sterility | Nationwide |
| Drug | CLASS II | Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) recalledClaravis | Teva Pharmaceuticals USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Isotretinoin Capsules, USP, 30 mg recalled by Teva Pharmaceuticals USAIsotretinoin | Teva Pharmaceuticals USA | Potency & Assay | 4 states |
| Drug | CLASS II | Isotretinoin Capsules, USP, 40 mg Prescription Pacs recalledIsotretinoin | Teva Pharmaceuticals USA | Potency & Assay | 4 states |
Other Leucovorin recalls
All 13| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Leucovorin Calcium for Injection, USP 100 mg/vial single-use vials recalled | Teva Pharmaceuticals USA | Sterility | Nationwide |
| Drug | CLASS II | Leucovorin Calcium for Injection, USP 350 mg/vial single-use vials recalled | Teva Pharmaceuticals USA | Sterility | Nationwide |
| Drug | CLASS II | Leucovorin Calcium for Injection, USP 350 mg/vial single-use vials recalled | Teva Pharmaceuticals USA | Sterility | Nationwide |
| Drug | CLASS II | Leucovorin Calcium for Injection, USP, 100 mg/vial, Single-Dose Vial recalled | Teva Pharmaceuticals USA | Sterility | Nationwide |
| Drug | CLASS II | Leucovorin Calcium for Injection, USP, 350 mg/vial recalled | Teva Pharmaceuticals USA | Sterility | Nationwide |